Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02172
European Journal of Endocrinology, Vol 155, Issue 1, 143-151
Copyright © 2006 by Society of the European Journal of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janner, M.
Right arrow Articles by Flück, C. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janner, M.
Right arrow Articles by Flück, C. E

CLINICAL STUDY

Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein

Marco Janner, Amit V Pandey1, Primus E Mullis and Christa E Flück

Pediatric Endocrinology and Diabetology, University Children’s Hospital Bern, Bern, Switzerland and 1 Theodor Kocher Institute, University of Bern, Bern, Switzerland

(Correspondence should be addressed to C E Flück; Email: christa.flueck{at}insel.ch)

Objective: A severely virilized 46, XX newborn girl was referred to our center for evaluation and treatment of congenital adrenal hyperplasia (CAH) because of highly elevated 17{alpha}-hydroxyprogesterone levels at newborn screening; biochemical tests confirmed the diagnosis of salt-wasting CAH. Genetic analysis revealed that the girl was compound heterozygote for a previously reported Q318X mutation in exon 8 and a novel insertion of an adenine between nucleotides 962 and 963 in exon 4 of the CYP21A2 gene. This 962_963insA mutation created a frameshift leading to a stop codon at amino acid 161 of the P450c21 protein.

Aim and methods: To better understand structure–function relationships of mutant P450c21 proteins, we performed multiple sequence alignments of P450c21 with three mammalian P450s (P450 2C8, 2C9 and 2B4) with known structures as well as with human P450c17. Comparative molecular modeling of human P450c21 was then performed by MODELLER using the X-ray crystal structure of rabbit P450 2B4 as a template.

Results: The new three dimensional model of human P450c21 and the sequence alignment were found to be helpful in predicting the role of various amino acids in P450c21, especially those involved in heme binding and interaction with P450 oxidoreductase, the obligate electron donor.

Conclusion: Our model will help in analyzing the genotype–phenotype relationship of P450c21 mutations which have not been tested for their functional activity in an in vitro assay.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
A. V. Pandey, P. Kempna, G. Hofer, P. E. Mullis, and C. E. Fluck
Modulation of Human CYP19A1 Activity by Mutant NADPH P450 Oxidoreductase
Mol. Endocrinol., October 1, 2007; 21(10): 2579 - 2595.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society of the European Journal of Endocrinology.